Correction to: Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy

DOI: https://doi.org/10.1093/hmg/ddae069
IF: 5.1214
2024-04-13
Human Molecular Genetics
Abstract:This is a correction to: Lan Weiss et al., Ceramide contributes to pathogenesis and may be targeted for therapy in VCP inclusion body myopathy, Human Molecular Genetics, Volume 29, Issue 24, 15 December 2020, Pages 3945–3953, https://doi.org/10.1093/hmg/ddaa248
genetics & heredity,biochemistry & molecular biology
What problem does this paper attempt to address?